Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.53
-0.47%
After-hours: Aug 15, 2025, 04:09 PM EDT

Tempest Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-41.84M -29.49M -35.71M -28.3M
Depreciation & Amortization
389K 381K 638K 374K
Stock-Based Compensation
5.3M 2.55M 1.56M 1.1M
Other Working Capital
8K -2.41M 867K -404K
Other Non-Cash Items
1.51M 1.88M 1.57M 1.48M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.61M -2.68M 868K -613K
Operating Cash Flow
-33.03M -27.36M -31.07M -25.96M
Capital Expenditures
-435K -170K -562K -135K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 38K
Investing Cash Flow
-435K -170K -562K -97K
Debt Repayment
-4.4M n/a -4.74M 15M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
307K n/a n/a 10.64M
Financial Cash Flow
24.5M 35.6M 11.4M 59.06M
Net Cash Flow
-8.96M 8.07M -20.23M 33.01M
Free Cash Flow
-33.46M -27.53M -31.63M -26.09M